Investing Profile

Thilo Schroeder

InvestorVC
Managing Partner at Nextech Invest
nextechinvest.com/team/Zurich, Switzerland
Photo of Thilo Schroeder, Managing Partner at Nextech Invest
Your Intro Paths to Thilo Schroeder

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Thilo is a member of
Universität Zürich | University of Zurich Network
19 CONNECTIONS
University of Sydney Network
14 CONNECTIONS
University of Zurich Network
12 CONNECTIONS
University of Zurich Network
12 CONNECTIONS

Find Thilo Schroeder on

cb
Current Investing Position
Nextech Invest Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
19

Thilo Schroeder is on these Sector & Stage Rankings

Thilo Schroeder's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Stipple Bio
Series AApr 2026$100M
$100M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Derek DiRocco (RA Capital Management)
Atavistik Bio
Series BMar 2026$40M
Series BDec 2025$120M
Series UnknownDec 2023$40M
Series AAug 2021$60M
$260M
Co-investors: John Josey (The Column Group), Tim Kutzkey (The Column Group), Josh Wolfe (Lux Research), Jeff Goater (The Column Group)
Parabilis Medicines
Series FJan 2026$310M
Series EMar 2024$150M
$800M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Elena Viboch (General Catalyst), Corey Goodman (venBio Partners), Jake Simson (RA Capital Management)
Circle Pharma
Series DSep 2024$90M
Series CJun 2021$66M
Series BMar 2020$45M
$200M
Co-investors: Peter Svennilson (The Column Group), Douglas Crawford (Mission BioCapital), Eric Anschutz
Alterome Therapeutics
Series BApr 2024$130M
Series AJan 2022$64M
$230M
Co-investors: Arjun Goyal (Vida Ventures, LLC), Carl Gordon (OrbiMed Advisors)
Exo Therapeutics
Series BOct 2021$78M
$78M
Silverback Therapeutics
Series CSep 2020$85M
Series BMar 2020$79M
$160M
Co-investors: Jonathan Root (U.S. Venture Partners (USVP))
Revolution Medicines
Series CJul 2019$100M
Series BApr 2018$56M
$180M
Co-investors: Larry Lasky (The Column Group)

Thilo Schroeder's Experience

Visiting Student The University of EdinburghPresent
Internship Micromet AGPresent
Master Student University of SydneyPresent
President SiROP AssociationPresent
PHD Student University of ZurichPresent
Member of the Board of Directors Blueprint MedicinesPresent
Member of the Board of Directors Peloton TherapeuticsPresent
Member of the Board of Directors ImaginAbPresent
Member Board Of Directors IDEAYA BiosciencesPresent
Member Board Of Directors REVOLUTION MedicinesPresent
Board Observer Black Diamond TherapeuticsPresent
Member Board Of Directors PMV Pharmaceuticals, Inc.Present
Board Member Silverback TherapeuticsPresent
Board Member Circle Pharma, Inc.Present
Board Member MOMA TherapeuticsPresent
Member Board Of Directors Atavistik BioPresent
Board Member Exo TherapeuticsPresent
Member Board Of Directors Alterome Therapeutics, IncPresent
Board Observer IDRxPresent
Board Observer CARGO TherapeuticsPresent
Member Board of Directors Synnovation TherapeuticsPresent
Board Observer Mariana OncologyPresent
Managing Partner Nextech InvestPresent

Thilo Schroeder's Education

Technische Universität Darmstadt Vordiplom Biology; Molecular biology
University of Zurich PhD, Biochemistry; Structural biology and protein engineering Biochemistry; Structural biology and protein engineering
Life Science Zurich Graduate School, ETH |University of the PhD Program, Molecular Life Science Molecular Life Science
University of Zurich of the PhD Program Molecular Life Science
Universität Zürich | University of Zurich PhD Biochemistry; Structural biology and protein engineering
ESBS 2006 Biotechnology; Protein biochemistry, process engineering

Investors who invest with Thilo Schroeder

Sign in with Google →

Scouts & Angels Affiliated With Thilo Schroeder

Sign in with Google →